Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

Capsule Surveillance System

K-Number: K213335 · 2022-01-14

Decision Date2022-01-14
Product CodeMWI
Advisory CommitteeCV
DecisionSubstantially Equivalent

Device Summary

Capsule Surveillance System is a medical device manufactured by Capsule Surveillance Technologies, Sas /Capsule Tech, Inc.. It received FDA 510(k) clearance on 2022-01-14 under approval number K213335. The device is classified under product code MWI. It was reviewed by the CV advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the Capsule Surveillance System?

Capsule Surveillance System is a medical device that received FDA 510(k) clearance on 2022-01-14. It is manufactured by Capsule Surveillance Technologies, Sas /Capsule Tech, Inc.. The 510(k) number is K213335.

When was Capsule Surveillance System approved by the FDA?

Capsule Surveillance System received FDA 510(k) clearance on 2022-01-14, under approval number K213335.

What company makes Capsule Surveillance System?

Capsule Surveillance System is manufactured by Capsule Surveillance Technologies, Sas /Capsule Tech, Inc..

What is the FDA product code for Capsule Surveillance System?

The FDA product code for Capsule Surveillance System is MWI.

Related Clinical Trials

Related PubMed Literature

Related Devices (Code: MWI)

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.